Effect of sleep apnea syndrome on the vascular endothelium;Conséquences du syndrome d'apnées du sommeil sur l'endothélium vasculaire

Revue Neurologique

Volumn 159, Issue 11 SUPPL., 2003, Pages

  Tharaux, P L ^a,b  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ENDOTHELIN; INSULIN; LEPTIN; NITRIC OXIDE; RENIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

CARDIOVASCULAR DISEASE; CATABOLISM; CONFERENCE PAPER; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SLEEP APNEA SYNDROME; STROKE; SYMPATHETIC NERVE; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANIMALS; CARDIOVASCULAR DISEASES; COMORBIDITY; ENDOTHELIUM, VASCULAR; HUMANS; LEPTIN; OXIDATIVE STRESS; RATS; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0344013065     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. ALEXANDER RW. (1995). Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension, 25: 155-161.
2. BIXLER EO, VGONTZAS AN, LIN HM et al. (2000). Association of hypertension and sleep-disordered breathing. Arch Intern Med, 160: 2289-2295
3. CELERMAJER DS, SORENSEN KE, GOOCH VM et al. (1992). Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340: 1111-1115.
4. CHIN K, SHIMIZU K, NAKAMURA T et al. (1999). Changes in intraabdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation, 100: 706-712.
5. DE CATERINA R, LIBBY P, PENG HB et al. (1995). Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest, 96: 60-68.
6. DUCHNA HW, GUILLEMINAULT C, STOOHS RA et al. (2000). Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med, 161: 187-191.
7. FORTUNO A, RODRIGUEZ A, GOMEZ-AMBROSI J et al. (2002). Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology, 143: 3555-3560.
8. GIBBONS GH, DZAU VJ. (1994). The emerging concept of vascular remodeling. N Engl J Med, 33, 1431-1438.
9. GRIMPEN F, KANNE P, SCHULZ E, HAGENAH G, HASENFUSS G, ANDREA S et al. (2000). Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J, 15: 320-325.
10. HERMANN DM, BASSETTI CL. (2003). Sleep-disordered breathing and stroke. Curr Opin Neurol, 16, 87-90.
11. HLA KM, YOUNG TB, BIDWELL T et al. (1994). Sleep apnea and hypertension: a population-based study. Ann Int Med, 120: 382-388.
12. IP MS, LAM B, CHAN LY et al. (2000). Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med, 162: 2166-2171.
13. IP MS, LAM KS, Ho C, TSANG KW, LAM W. (2000b). Serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 118: 580-586.
14. KANAGY NL, WALKER BR, NELIN LD. (2001). Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension, 37: 511-515.
15. KATO M, ROBERTS-THOMSON P, PHILLIPS BG et al. (2000). Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation, 102: 2607-2610.
16. KOUREMBANAS S, MARSDEN PA, MCQUILLAN LP, FALLER DV. (1991). Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest, 88: 1054-1057.
17. KRAICZI H, HEDNER J, PEKER Y, Carlson J. (2000). Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol, 89: 493-498.
18. NIETO FJ, YOUNG TB, LIND BK et al. (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA, 283: 1829-1836.
19. ODA A, TANIGUCHI T, YOKOYAMA M. (2001). Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci, 47: 141-150.
20. OHGA E, NAGASE T, TOMITA T et al. (1999). Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol, 87: 10-14.
21. PEPPARD PE, YOUNG T, PALTA M, SKATRUD J. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 342: 1378-1384.
22. PHILLIPS BG, NARKIEWICZ K, PESEK CA, HAYNES WG, DYKEN ME, SOMERS VK. (1999). Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens, 17: 61-66.
23. RIDKER PM, GABOURY GL, CONLIN PR, SEELY EW, WILLIAMS GH, VAUGHAN DE. (1993). Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation, 87: 1969-1973.
24. ROSENBAUM M, NICOLSON M, HIRSCH J, MURPHY E, CHU F, LEIBEL RL. (1997). Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab, 82: 3647-3654.
25. ROSENBAUM M, NICOLSON M, HIRSCH J et al. (1996). Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab, 81: 3424-3427
26. SCHÄFER H, PAULEIT D, SUDHOP T, GOUNI-BERTHOLD I, EWIG S, BERTHOLD HK. (2002). Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest, 122: 829-839.
27. SCHULZ R, SCHMIDT D, BLUM A et al. (2000). Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax, 55: 1046-1051.
28. SIERRA-HONIGMANN MR, NATH AK, MURAKAMI C et al. (1998). Biological action of leptin as an angiogenic factor. Science, 281: 1683-1686.
29. SINGHAL A, FAROOQI JS, COLE TJ, et al. (2002). The influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation, 106: 1919-1924.
30. SOMERS VK, DYKEN ME, CLARY MP, ABBOUD FM. (1995). Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest, 96: 1897-1904.
31. THARAUX PL, CHATZIANTONIOU C, CASELLAS D, FOUASSIER L, ARDAILLOU, DUSSAULE JC. (1999). Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats. Circulation, 99: 2185-2191
32. YAMAGISHI SI, EDELSTEIN D, DU XL, KANEDA Y, GUZMAN M, BROWNLEE M. (2001). Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem, 276: 25096-25100.
33. YOUNG T, PALTA M, DEMPSEY J, SKATRUD J, WEBER S, BADR S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med, 328: 1230-1235.